News | December 20, 2025
Pfizer and Cipla forge exclusive marketing and distribution pact for key brands in India
This marks the first partnership between Pfizer and Cipla in India
This marks the first partnership between Pfizer and Cipla in India
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
The new facility is expected to generate 500-600 new jobs in the region
Hansoh Pharma will receive an upfront payment in the low double-digit millions
India plays a critical role in Bristol Myers Squibb’s global strategy
Imsidolimab, an IgG4 IL-36 receptor antagonist, works by inhibiting IL-36 receptor signaling, directly addressing the deficiency in the IL-36RA regulator common in GPP patients
This launch is part of the company's strategy to expand its nutraceutical portfolio
Ryght AI tackles these hurdles with its AI Site Twin platform
Subscribe To Our Newsletter & Stay Updated
